Citadel Advisors
CYRX icon

Citadel Advisors’s CryoPort CYRX Stock Holding History

Citadel Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$754K Sell
91,100
-61,200
-40% -$553K ﹤0.01% 8343
2025
Q4 		$1.46M Sell
152,300
-45,300
-23% -$428K ﹤0.01% 6566
2025
Q3 		$1.87M Buy
197,600
+91,300
+86% +$769K ﹤0.01% 6203
2025
Q2 		$793K Sell
106,300
-12,300
-10% -$76.3K ﹤0.01% 7587
2025
Q1 		$721K Buy
118,600
+65,700
+124% +$455K ﹤0.01% 7685
2024
Q4 		$412K Sell
52,900
-13,400
-20% -$99.9K ﹤0.01% 8986
2024
Q3 		$538K Buy
66,300
+36,800
+125% +$301K ﹤0.01% 8105
2024
Q2 		$204K Buy
29,500
+3,500
+13% +$47.1K ﹤0.01% 9893
2024
Q1 		$460K Sell
26,000
-137,000
-84% -$2.17M ﹤0.01% 8574
2023
Q4 		$2.52M Buy
163,000
+8,800
+6% +$115K ﹤0.01% 4963
2023
Q3 		$2.11M Buy
154,200
+58,000
+60% +$854K ﹤0.01% 5109
2023
Q2 		$1.66M Buy
96,200
+3,500
+4% +$71.6K ﹤0.01% 5489
2023
Q1 		$2.22M Sell
92,700
-35,900
-28% -$781K ﹤0.01% 5156
2022
Q4 		$2.23M Buy
128,600
+80,300
+166% +$1.69M ﹤0.01% 5272
2022
Q3 		$1.18M Sell
48,300
-38,300
-44% -$1.32M ﹤0.01% 6634
2022
Q2 		$2.68M Sell
86,600
-86,400
-50% -$2.3M ﹤0.01% 4967
2022
Q1 		$6.04M Sell
173,000
-62,400
-27% -$2.36M ﹤0.01% 3814
2021
Q4 		$13.9M Buy
235,400
+89,300
+61% +$6.18M ﹤0.01% 2527
2021
Q3 		$9.72M Sell
146,100
-9,100
-6% -$561K ﹤0.01% 3132
2021
Q2 		$9.79M Sell
155,200
-93,600
-38% -$5.27M ﹤0.01% 3114
2021
Q1 		$12.9M Buy
248,800
+23,200
+10% +$1.41M ﹤0.01% 2594
2020
Q4 		$9.9M Sell
225,600
-25,400
-10% -$1.21M ﹤0.01% 2651
2020
Q3 		$11.9M Buy
251,000
+158,800
+172% +$6.43M ﹤0.01% 2088
2020
Q2 		$2.79M Buy
92,200
+61,700
+202% +$1.37M ﹤0.01% 3982
2020
Q1 		$521K Sell
30,500
-16,600
-35% -$291K ﹤0.01% 6394
2019
Q4 		$775K Buy
47,100
+7,600
+19% +$113K ﹤0.01% 6060
2019
Q3 		$646K Buy
+39,500
New +$792K ﹤0.01% 6309

Other funds holding CYRX

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

Citadel Advisors's CYRX Position: Q1 2026 in Review

Citadel Advisors reduced its CryoPort (CYRX) stake by 21% in Q1 2026, selling an estimated $444K and leaving 183,178 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #6684.

Citadel Advisors first reported a position in CYRX in Q2 2018 and has held it in 27 quarters since. The position peaked at $12.7M in Q1 2021. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • Citadel Advisors held 183,178 shares of CryoPort worth $1.52M as of Q1 2026.
  • Citadel Advisors sold 49,182 CryoPort shares in Q1 2026, an estimated $444K.
  • CryoPort made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6684 holding.
  • Citadel Advisors first reported a position in CryoPort in Q2 2018 and has held it in 27 quarters since.
  • Citadel Advisors's CryoPort position peaked at $12.7M in Q1 2021.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.